VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine
10. Mai 2018 07:30 ET
|
VBI Vaccines, Inc.
CMV neutralizing antibodies against fibroblast cell infection induced in 100% of subjects who received the highest doseSafe and well-tolerated at all doses with no safety signals observedConference...